Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Abiraterone acetate plus LHRH therapy versus abiraterone acetate while sparing LHRH therapy in patients with progressive, metastatic and chemotherapy-naïve, castration-resistant prostate cancer (SPARE): study protocol for a randomized controlled trial

  • Carsten-Henning Ohlmann1, 5Email author,
  • Michelle Jäschke1,
  • Peter Jaehnig2,
  • Susane Krege3, 5,
  • Jürgen Gschwend4, 5,
  • Heidrun Rexer5 and
  • Michael Stöckle1
Trials201718:457

https://doi.org/10.1186/s13063-017-2195-x

Received: 15 May 2017

Accepted: 14 September 2017

Published: 4 October 2017

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
15 May 2017 Submitted Original manuscript
31 Aug 2017 Author responded Author comments - Carsten Ohlmann
Resubmission - Version 2
31 Aug 2017 Submitted Manuscript version 2
13 Sep 2017 Author responded Author comments - Carsten Ohlmann
Resubmission - Version 3
13 Sep 2017 Submitted Manuscript version 3
Publishing
14 Sep 2017 Editorially accepted
4 Oct 2017 Article published 10.1186/s13063-017-2195-x

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Department of Urology, Saarland University
(2)
PJ statistics
(3)
Department of Urology, Klinikum Essen Mitte
(4)
Department of Urology, Klinikum Rechts der Isar, Technical University Munich
(5)
Working Group on Urological Oncology (AUO), Germany Cancer Society

Advertisement